Answers are grounded in this paper and cite their sources.
VMAT treatment in preoperative CRT for LARC showed the potential to substantially reduce high-grade acute and late toxicity. Importantly, we could demonstrate that VMAT irradiation did not impair short-term oncological results. We conclude, that the reduced toxicity after VMAT irradiation may pave the way for more efficient systemic therapies, and hopefully improved patient survival in the multimodal treatment of LARC.
No takes yet. Share an insight, caveat, or question.
Dröge et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: